Light chain multiple myeloma in a patient with long-standing rheumatoid arthritis.
Alexopoulou
Alexandra
A
Dourakis
Spyros P
SP
Apostolopoulou
Alexandra
A
Kandyli
Anna
A
Pandelidaki
Helen
H
Archimandritis
Athanasios J
AJ
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018501:Antirheumatic Agents; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy / Q000652:urine; D005260:Female; D017612:Gold Compounds / Q000627:therapeutic use; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007147:Immunoglobulin Light Chains / Q000652:urine*; D008727:Methotrexate / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000150:complications* / Q000473:pathology / Q000652:urine; D010198:Pancytopenia / Q000209:etiology / Q000473:pathology; D010396:Penicillamine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D018501:Antirheumatic Agents; D017612:Gold Compounds; D007147:Immunoglobulin Light Chains; D006886:Hydroxychloroquine; D010396:Penicillamine; D008727:Methotrexate